Enhancer ID: | E_01_0226 |
Species: | human |
Position : | chr17:39401537-39403537 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Thyroid cancer |
Pubmed ID: | 31615896 |
Enhancer experiment: | Western blot,PCR |
Enhancer experiment description: | In addition, other TFs and cofactors, such as KLFs, STAT5, PBX1, Krox20, AP1 , ATFs, GATA2/3 , TAF8 , and Mediator subunits (MED1, MED14 and NED23), have been reported to be involved in regulating either adipocyte commitment or differentiation in cell line and/or mouse models. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | In addition, other TFs and cofactors, such as KLFs, STAT5, PBX1, Krox20, AP1 , ATFs, GATA2/3 , TAF8 , and Mediator subunits (MED1, MED14 and NED23), have been reported to be involved in regulating either adipocyte commitment or differentiation in cell line and/or mouse models. |
TF name : | MED1(AI480703,CRSP210,DRIP205,PBP,Pparbp,TRAP220,TRIP-2,l11Jus15) |
TF experiment: | Western blot,PCR |
TF experiment description: | In addition, other TFs and cofactors, such as KLFs, STAT5, PBX1, Krox20, AP1 , ATFs, GATA2/3 , TAF8 , and Mediator subunits (MED1, MED14 and NED23), have been reported to be involved in regulating either adipocyte commitment or differentiation in cell line and/or mouse models. |
Enhancer function : | In addition, other TFs and cofactors, such as KLFs, STAT5, PBX1, Krox20, AP1 , ATFs, GATA2/3 , TAF8 , and Mediator subunits (MED1, MED14 and NED23), have been reported to be involved in regulating either adipocyte commitment or differentiation in cell line and/or mouse models. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
In addition, other TFs and cofactors, such as KLFs, STAT5, PBX1, Krox20, AP1 , ATFs, GATA2/3 , TAF8 , and Mediator subunits (MED1, MED14 and NED23), have been reported to be involved in regulating either adipocyte commitment or differentiation in cell line and/or mouse models. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
MED1 | Activation of gene expression by SREBF (SREBP) | reactome | 42 |
MED1 | BMAL1:CLOCK,NPAS2 activates circadian gene expression | reactome | 42 |
MED1 | Circadian Clock | reactome | 49 |
MED1 | Coregulation of Androgen receptor activity | pid | 61 |
MED1 | Generic Transcription Pathway | reactome | 358 |
MED1 | Hedgehog | netpath | 39 |
MED1 | Nuclear Receptor transcription pathway | reactome | 51 |
MED1 | PPARA activates gene expression | reactome | 113 |
MED1 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | reactome | 20 |
MED1 | RORA activates gene expression | reactome | 27 |
MED1 | RXR and RAR heterodimerization with other nuclear receptor | pid | 26 |
MED1 | Transcriptional activation of mitochondrial biogenesis | reactome | 43 |
MED1 | Transcriptional regulation of white adipocyte differentiation | reactome | 79 |
MED1 | Validated nuclear estrogen receptor alpha network | pid | 65 |
MED1 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | reactome | 29 |